An investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) was generally well tolerated and resulted in the production of both binding and neutralizing antibodies in healthy adult volunteers, according to interim results from a phase 1 trial published today. at New England Journal of Medicine. The experimental vaccine …
Read More »Emory-tested COVID-19 vaccine is safe, generates immune response, preliminary results show | Emory University
